Thermo Fisher Scientific Catumaxomab Recombinant Human Monoclonal Antibody

Applications

• ELISA (Assay-dependent)

Product Specifications

Product Specific Information

• Endotoxin level < 0.01 EU/µg (LAL method)
• Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
• Store at 2–8°C for one week.
• Store at -20 to -80°C for twelve months from the date of receipt.

Target Information

Catumaxomab is a trifunctional monoclonal antibody developed for use in cancer treatment. It binds to T-cells, accessory immune cells, and cancer cells.
Initially authorized by the European Medicines Agency (April 2009) for malignant ascites treatment, its EU authorization was withdrawn in June 2017 at the manufacturer’s request due to insolvency.
Approved in Canada (May 2012) for the same indication under the brand name Removab.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.